Furiex Pharmaceuticals, Inc. is a drug development collaboration company using innovative clinical development design to accelerate and increase the value of partnered drug programs by advancing them to Phase III in a cost-efficient manner.
EXPERT. FOCUSED. FAST.
30 Aug >> Furiex to Present at Rodman & Renshaw Conference in New York Sept. 12-15
More details >
11 Aug >> Furiex Reports Second Quarter 2010 Financial Results
Sign up to Listen
More details >
01 Jul >> Furiex Pharmaceuticals Announces Issuance of U.S. Patent for Dapoxetine Method of Treatment
More details >
Furiex has a strong, diversified product portfolio and pipeline with two products on the market and multiple therapeutic candidates, including late-stage programs, in development.